Diaceutics PLC
DXRX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £105,989 | £73,277 | £63,533 | £85,615 |
| - Cash | £12,744 | £16,667 | £19,841 | £19,675 |
| + Debt | £1,060 | £1,205 | £1,329 | £1,561 |
| Enterprise Value | £94,305 | £57,815 | £45,021 | £67,501 |
| Revenue | £32,158 | £23,699 | £19,504 | £13,943 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Gross Profit | £28,270 | £19,706 | £14,037 | £10,566 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| EBITDA | £2,773 | £2,359 | £3,608 | £2,349 |
| % Margin | 8.6% | 10% | 18.5% | 16.8% |
| Net Income | -£1,703 | -£1,746 | £724 | £561 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| % Growth | 2.4% | -346.4% | 27.3% | – |
| Operating Cash Flow | £651 | £1,311 | £5,148 | £570 |
| Capital Expenditures | -£4,632 | -£4,855 | -£4,870 | -£5,601 |
| Free Cash Flow | -£3,981 | -£3,544 | £278 | -£5,031 |